Celiac Disease School for Women Living on a Gluten-free Diet (CDST)

Structured Education of Swedish Celiac Women Living on a Gluten-free Diet for Years

Swedish celiac disease women living on a gluten-free diet for years report poorer subjective health and more bowel complaints than Swedish women of same age in general population.

The investigators hypothesis is that the women participating in an education programme based on problem based learning will show higher degree of perceived health than the women receiving usual care.

Study Overview

Detailed Description

Celiac disease is a disorder of the small intestines triggered by dietary gluten, a protein in wheat-containing foods. Living with is far from easy and associated with restrictions and various dilemmas in daily life, leading to depressed mood and reduced well-being, particularly in women. We decided to include 100 celiac disease women on a gluten-free diet into a randomized controlled education trial in order to compare problem-based learning with usual care. Outcome measures will be two frequently employed questionnaires: PGWB (Psychological Well-being Index) to monitor Well-being and GSRS (Gastrointestinal Symptom Rating Scale) to measure the rate bowel symptoms as assessed at 6 months after the intervention.

Study Type

Interventional

Enrollment (Anticipated)

106

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Norrkoping, Sweden, S-601 82
        • Recruiting
        • Norrkoping Hospital,
        • Contact:
        • Contact:
        • Principal Investigator:
          • Claes Hallert, MD, PhD
        • Principal Investigator:
          • Lisa Jacobsson, MSc RN
        • Principal Investigator:
          • Maria Friedrichsen, MD, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Women aged 20 yrs or above with Celiac disease treated for at least five years

Exclusion Criteria:

  • Anticipated inability to comply the trial protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual care of celiac disease women
Written information corresponding to that offered when seeking medical advice for celiac disease in primary care
Written information corresponding to that offered when seeking medical advice for well treated celiac disease in the primary care.
Other Names:
  • Coeliac disease guidelines
Experimental: Celiac School
Structured education using problem-based learning at 10 sessions
Structured education of adult celiac patients at 10 sessions.
Other Names:
  • Patient education
  • Counselling

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Subjective health and well-being
Time Frame: 6 months
Gastrointestinal symptoms and Psychological well-being
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Gastrointestinal symptoms and Psychological well-being
Time Frame: 6 months
Two questionnaires: Psychological General Well-Being Index and the Gastrointestinal Symptom Rating Scale.
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Study Director: Claes Hallert, MD, PhD, Norrkoping Hospitalö

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

August 1, 2008

Primary Completion (Actual)

January 1, 2009

Study Completion (Anticipated)

March 1, 2010

Study Registration Dates

First Submitted

March 16, 2010

First Submitted That Met QC Criteria

March 16, 2010

First Posted (Estimate)

March 17, 2010

Study Record Updates

Last Update Posted (Estimate)

March 17, 2010

Last Update Submitted That Met QC Criteria

March 16, 2010

Last Verified

January 1, 2001

More Information

Terms related to this study

Other Study ID Numbers

  • FORSS-80731
  • M218-08 (Other Identifier: Ethics Committee at Linkoping University, Linkoping Sweden)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Counseling

Clinical Trials on Usual care of celiac disease women

3
Subscribe